Follow
Eva JA Morris
Eva JA Morris
Verified email at ndph.ox.ac.uk
Title
Cited by
Cited by
Year
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer …
MP Coleman, D Forman, H Bryant, J Butler, B Rachet, C Maringe, U Nur, ...
The Lancet 377 (9760), 127-138, 2011
15282011
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
MM Mafham, E Spata, R Goldacre, D Gair, P Curnow, M Bray, S Hollings, ...
The Lancet 396 (10248), 381-389, 2020
7752020
Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study
NP West, EJA Morris, O Rotimi, A Cairns, PJ Finan, P Quirke
The lancet oncology 9 (9), 857-865, 2008
5762008
Global trends in colorectal cancer mortality: projections to the year 2035
M Araghi, I Soerjomataram, M Jenkins, J Brierley, E Morris, F Bray, ...
International journal of cancer 144 (12), 2992-3000, 2019
5512019
Surgical management and outcomes of colorectal cancer liver metastases
EJA Morris, D Forman, JD Thomas, P Quirke, EF Taylor, L Fairley, ...
Journal of British Surgery 97 (7), 1110-1118, 2010
4342010
Palliative biliary stents for obstructing pancreatic carcinoma
AC Moss, E Morris, P MacMathuna
Cochrane database of systematic reviews, 2006
4142006
Thirty-day postoperative mortality after colorectal cancer surgery in England
EJA Morris, EF Taylor, JD Thomas, P Quirke, PJ Finan, MP Coleman, ...
Gut 60 (6), 806-813, 2011
3542011
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study
EJA Morris, R Goldacre, E Spata, M Mafham, PJ Finan, J Shelton, ...
The lancet Gastroenterology & hepatology 6 (3), 199-208, 2021
3492021
World Endoscopy Organization consensus statements on post-colonoscopy and post-imaging colorectal cancer
MD Rutter, I Beintaris, R Valori, HM Chiu, DA Corley, M Cuatrecasas, ...
Gastroenterology 155 (3), 909-925. e3, 2018
3152018
Reporting colorectal cancer
P Quirke, E Morris
Histopathology 50 (1), 103-112, 2007
2842007
Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results
AC Moss, E Morris, J Leyden, P MacMathuna
Cancer treatment reviews 33 (2), 213-221, 2007
2772007
Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000–2007
C Maringe, S Walters, B Rachet, J Butler, T Fields, P Finan, R Maxwell, ...
Acta oncologica 52 (5), 919-932, 2013
2562013
Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction
AC Moss, E Morris, J Leyden, P MacMathuna
European journal of gastroenterology & hepatology 19 (12), 1119-1124, 2007
2512007
Emergency presentation of cancer and short-term mortality
S McPhail, L Elliss-Brookes, J Shelton, A Ives, M Greenslade, S Vernon, ...
British journal of cancer 109 (8), 2027-2034, 2013
2342013
Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene?
E Morris, P Quirke, JD Thomas, L Fairley, B Cottier, D Forman
Gut 57 (12), 1690-1697, 2008
2242008
High hospital research participation and improved colorectal cancer survival outcomes: a population-based study
A Downing, EJA Morris, N Corrigan, D Sebag-Montefiore, PJ Finan, ...
Gut 66 (1), 89-96, 2017
1952017
Post-colonoscopy colorectal cancer (PCCRC) rates vary considerably depending on the method used to calculate them: a retrospective observational population-based study of PCCRC …
EJA Morris, MD Rutter, PJ Finan, JD Thomas, R Valori
Gut 64 (8), 1248-1256, 2015
1852015
Identifying stage III colorectal cancer patients: the influence of the patient, surgeon, and pathologist
EJA Morris, NJ Maughan, D Forman, P Quirke
Journal of clinical oncology 25 (18), 2573-2579, 2007
1742007
Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis
A Downing, EJA Morris, M Richards, J Corner, P Wright, ...
Journal of clinical oncology 33 (6), 616-624, 2015
1702015
Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology
EJA Morris, NJ Maughan, D Forman, P Quirke
Gut 56 (10), 1419-1425, 2007
1642007
The system can't perform the operation now. Try again later.
Articles 1–20